Domínguez, Raúl O <br/><br/>
Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer's disease patients.  [electronic resource] 

 -  Diabetes research and clinical practice  Oct 2012 
 - 68-74 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8227 
<br/><br/><label>Standard No.: </label>10.1016/j.diabres.2012.05.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alzheimer Disease--blood<br/>Argentina<br/>Cognition Disorders--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Disease Progression<br/>Female<br/>Geriatric Assessment<br/>Hippocampus--drug effects<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Insulin--metabolism<br/>Longitudinal Studies<br/>Male<br/>Neuropsychological Tests<br/>Oxidative Stress<br/>Pilot Projects<br/>Psychiatric Status Rating Scales<br/>Rosiglitazone<br/>Severity of Illness Index<br/>Thiazolidinediones--pharmacology